Long-term exposure to air pollution from traffic, even at relatively low concentrations, may increase the risk of fatty liver disease, according to a new…
News
BILIARY ATRESIA
NewsBiliary atresia blood markers augur post-Kasai liver transplant need
Children with biliary atresia who have higher blood levels of the matrix metalloproteinase 7 (MMP-7) and alkaline phosphatase (ALP) enzymes at the time of…
HEPATITIS
NewsVirtual clinic for liver diseases opens to US patients
A virtual clinic for liver diseases, including hepatitis, has begun treating patients. The LiverRight Hepatology Clinic offers same-week video visits to adults who…
CHOLANGITIS
NewsPoor primary biliary cholangitis outcomes tied to two antibodies
Testing positive for the self-reactive anti-gp210 and anti-centromeric antibodies significantly increases the risk of poor liver-related outcomes for people with primary biliary cholangitis (PBC),…
LIVER DISEASE
NewsAwareness month focuses on challenges for rural communities
February is Rare Liver Diseases Month, and the Global Liver Institute (GLI) is promoting a series of activities and events to raise awareness…
FATTY LIVER DISEASE
NewsWeight loss surgery may protect liver with MASH-related cirrhosis
Weight loss surgery significantly lowers the risk of serious liver complications among obese people with cirrhosis, or irreversible liver scarring and damage, due to metabolic…
ALAGILLE SYNDROME
NewsLivmarli relieves itch in adolescents with Alagille syndrome: Analysis
Treatment with Livmarli (maralixibat) is effective for relieving itch in adolescents with Alagille syndrome, according to a new analysis of previous clinical trials.
Babies born extremely prematurely who were given a dose of the hepatitis B virus (HBV) vaccine within a day of being born were not…
CHOLANGITIS
NewsThree-factor tool may predict response to UDCA in PBC: Study
A predictive tool that incorporates several blood biomarkers may help to identify primary biliary cholangitis (PBC) patients who are less likely to respond to treatment…
A genetic variant unique to East Asians increases the risk of intrahepatic cholestasis of pregnancy (ICP) by more than 16 times, but it likely…
Recent Posts
- Experimental ICP drug volixibat shows early promise for mothers, babies
- Celebrating a major milestone with a 5th birthday party for the ages
- In proof-of-concept trial, daily pill lowers blood, liver fat levels in MASLD
- Rare biliary atresia variant linked to better clinical outcomes: China study
- New test detects hepatitis B in 1 hour with a finger prick: Study